212 related articles for article (PubMed ID: 12469209)
21. [Mechanism of oncogenesis by human T-cell leukemia virus type 1].
Matsuoka M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):10-3. PubMed ID: 20087027
[TBL] [Abstract][Full Text] [Related]
22. [The human T-cell leukemia virus type I (HTLV-I) tax protein induces apoptosis].
Yamada T
Nihon Rinsho; 1996 Jul; 54(7):1855-9. PubMed ID: 8741678
[TBL] [Abstract][Full Text] [Related]
23. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
Barmak K; Harhaj E; Grant C; Alefantis T; Wigdahl B
Virology; 2003 Mar; 308(1):1-12. PubMed ID: 12706085
[TBL] [Abstract][Full Text] [Related]
24. Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease.
Oh U; Yamano Y; Mora CA; Ohayon J; Bagnato F; Butman JA; Dambrosia J; Leist TP; McFarland H; Jacobson S
Ann Neurol; 2005 Apr; 57(4):526-34. PubMed ID: 15786444
[TBL] [Abstract][Full Text] [Related]
25. HTLV-1 and associated adult T-cell leukemia/lymphoma.
Mahieux R; Gessain A
Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
[TBL] [Abstract][Full Text] [Related]
26. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
Carod-Artal FJ
Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
[TBL] [Abstract][Full Text] [Related]
27. Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression.
Lin HC; Hickey M; Hsu L; Medina D; Rabson AB
Virology; 2005 Aug; 339(1):1-11. PubMed ID: 15964046
[TBL] [Abstract][Full Text] [Related]
28. Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients.
Cartier L; Ramirez E
Arch Virol; 2005 Apr; 150(4):743-53. PubMed ID: 15592888
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
[TBL] [Abstract][Full Text] [Related]
30. [Virological aspects of HTLV-1 infection and new therapeutical concepts].
Mahieux R
Bull Soc Pathol Exot; 2011 Aug; 104(3):181-7. PubMed ID: 21607661
[TBL] [Abstract][Full Text] [Related]
31. The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).
Shuh M; Beilke M
Microsc Res Tech; 2005 Nov; 68(3-4):176-96. PubMed ID: 16276549
[TBL] [Abstract][Full Text] [Related]
32. Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis.
Perandin F; Cariani A; Bonfanti C; Trainini L; Magoni M; Manca N
Neurol Sci; 2006 Sep; 27(4):257-60. PubMed ID: 16998729
[TBL] [Abstract][Full Text] [Related]
33. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
34. The multifaceted oncoprotein Tax: subcellular localization, posttranslational modifications, and NF-κB activation.
Kfoury Y; Nasr R; Journo C; Mahieux R; Pique C; Bazarbachi A
Adv Cancer Res; 2012; 113():85-120. PubMed ID: 22429853
[TBL] [Abstract][Full Text] [Related]
35. In vitro cytoskeleton changes of mouse neurons induced by purified HTLV-1, and PBMC from HAM/TSP patients and HTLV-1 carriers.
Ramirez E; Cartier L; Flores R
Arch Virol; 2004 Dec; 149(12):2307-17. PubMed ID: 15338322
[TBL] [Abstract][Full Text] [Related]
36. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
[TBL] [Abstract][Full Text] [Related]
37. HTLV-1 Tax and adult T-cell leukemia.
Giam CZ; Jeang KT
Front Biosci; 2007 Jan; 12():1496-507. PubMed ID: 17127397
[TBL] [Abstract][Full Text] [Related]
38. Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.
Tabakin-Fix Y; Azran I; Schavinky-Khrapunsky Y; Levy O; Aboud M
Carcinogenesis; 2006 Apr; 27(4):673-81. PubMed ID: 16308315
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the GATA3 promoter by human T-cell lymphotropic virus type I Tax protein.
Gilli SC; Salles TS; Saad ST
J Cell Biochem; 2004 Dec; 93(6):1178-87. PubMed ID: 15486968
[TBL] [Abstract][Full Text] [Related]
40. High production of RANTES and MIP-1alpha in the tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Montanheiro P; Vergara MP; Smid J; da Silva Duarte AJ; de Oliveira AC; Casseb J
J Neuroimmunol; 2007 Aug; 188(1-2):138-42. PubMed ID: 17588676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
